Astrazeneca Canada Inc. v. Apotex Inc., 2011 FC 505 (Esomeprazole*)

Justice Crampton - 2011-05-24

Read full decision. Automatically generated summary:

This motion was brought by the Plaintiffs for, among other things, an interlocutory injunction to restrain the Defendant and certain associated individuals from making, constructing, importing, exporting, using, offering to sell or selling to others to be used, Apo-Esomeprazole and/or esomeprazole magnesium pending the trial of this action, which is scheduled to begin in September, 2013.

Decision relates to:


Canadian Intellectual Property